Cannabinoid agonists arrest tumor progression in a rodent model of malignant glioma. Will these molecules provide a starting point for new strategies for anti-cancer therapy (313–319)?
This is a preview of subscription content, log in via an institution to check access.
References
Christison, R. in A Dispensatory, or Commentary on the Pharmacopoeias of Great Britain (and the United States) 971–974 (Lea and Blanchard, Philadelphia, 1848).
Adams, R. Marihuana. Harvey Lect. 37, 168 ( 1941).
Gaoni, Y. & Mechoulam, R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646–1647 ( 1964).
Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. & Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561–564 (1990).
Piomelli, D., Beltramo, M., Giuffrida, A. & Stella, N. Endogenous cannabinoid signaling. Neurobiol. Disease, 5 462–473 (1998).
Galve-Roperh, I. et al. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation . Nature Med. 6, 313–319 (2000).
Matsuda, L.A. Molecular aspects of cannabinoid receptors. Critical Rev. Neurobiol. 11, 143–166 ( 1997).
Kolesnick, R.N. & Krönke, M. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60, 643–665 (1998).
Avgeropoulos, N.G. & Batchelor, T.T. New treatment strategies for malignant gliomas. Oncologist 4, 209–224 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Piomelli, D. Pot of gold for glioma therapy. Nat Med 6, 255–256 (2000). https://doi.org/10.1038/73088
Issue Date:
DOI: https://doi.org/10.1038/73088
- Springer Nature America, Inc.
This article is cited by
-
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis
Investigational New Drugs (2010)